Results 101 to 110 of about 16,624 (211)

A RETROSPECTIVE ANALYSIS OF REPURPOSED THERAPEUTICS USED DURING THE DELTA VARIANT INDUCED COVID-19 CRISIS OF INDIA, 2021

Медицина в Кузбассе, 2023
COVID-19 has led to a major worldwide health and economic crisis, with more than 27 million people having contracted the disease and more than 800 000 deaths.
Srinivasa Jayachandra, Sadhana Sonti, Vijaya Vathsa, C.M.A. Beliappa, Praneetha Achanta   +4 more
doaj  

Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models

Viruses, 2018
Zika virus (ZIKV) has recently emerged as a new public health threat. ZIKV infections have caused a wide spectrum of neurological diseases, such as Guillain–Barré syndrome, myelitis, meningoencephalitis, and congenital microcephaly.
Ji-Ae Kim, Rak-Kyun Seong, Mukesh Kumar, Ok Sarah Shin   +3 more
doaj   +1 more source

Ebola virus disease 2014 [PDF]

, 2014
Ebola virus disease was irst described in 1976 originating from the Ebola River in the Democratic Republic of Congo. Since then, Ebola virus has become an important public health threat in Africa, and now it is of great concern worldwide due to the ...
Arellanos Soto, Daniel, Bravo de la Cruz, Verónica, Galán Huerta, Kame Alberto, Ramos Jiménez, Javier, Rivas Estilla, Ana María   +4 more
core  

Ebola hemorrhagic fever: outbreaks, modeling, and vaccine development [PDF]

Master of ScienceDepartment of Biological & Agricultural EngineeringCaterina M. ScoglioLisa R. WilkenBetween the years 2014 and 2015, the world experienced a catastrophic outbreak of Ebola virus, which killed over 26,000 people.
Ahmadi Fard, Ala
core  

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

BMC Infectious Diseases
Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral activity against SARS-CoV-2.
Viravarn Luvira, William H. K. Schilling, Podjanee Jittamala, James A. Watson, Simon Boyd, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J. Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J. Callery, Shivani Singh, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato S. Aguiar, Franciele M. Santos, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mallika Imwong, Walter R. J. Taylor, Vasin Chotivanich, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas P. J. Day, Mauro M. Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J. White, the PLATCOV Collaborative Group   +35 more
doaj   +1 more source

Ebola virus disease complicated with viral interstitial pneumonia: a case report [PDF]

, 2015

core   +1 more source

ICU admission and favipiravir

Northern Clinics of Istanbul, 2021
Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj   +1 more
openaire   +2 more sources

Ebola Virus Infection: Overview and Update on Prevention and Treatment [PDF]

, 2015

core   +1 more source

Virology [PDF]

, 2017
吉田 与志博, 大野 歩, 大黒 徹, 山田 博司, 白木 公康, 矢島 美彩子, 谷 英樹   +6 more
core   +2 more sources

WHO collaborative study to assess the suitability of the 1st International Standard and the 1st International Reference Panel for antibodies to Ebola virus [PDF]

, 2017
A WHO international collaborative study was undertaken to evaluate preparations of Ebola virus disease (EVD) convalescent plasmas for their suitability to serve as the WHO 1st International Standard (IS) and the WHO 1st International Reference Panel (IRP)
Atkinson, E, Di Caro, A, Hassall, M, Hockley, J, MacLennan, S, Mattiuzzo, G, Minor, PD, Olaussen, RW, Page, M, Rigsby, P, Rijal, P, Semple, MG, Stone, L, Stramer, S, Wilkinson, DE   +14 more
core